AU768029B2 - Method for quantifying transforming growth factor-beta1 and method for detecting cancer by using same - Google Patents

Method for quantifying transforming growth factor-beta1 and method for detecting cancer by using same Download PDF

Info

Publication number
AU768029B2
AU768029B2 AU41471/00A AU4147100A AU768029B2 AU 768029 B2 AU768029 B2 AU 768029B2 AU 41471/00 A AU41471/00 A AU 41471/00A AU 4147100 A AU4147100 A AU 4147100A AU 768029 B2 AU768029 B2 AU 768029B2
Authority
AU
Australia
Prior art keywords
tgf
receptor
antibody
specific
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU41471/00A
Other languages
English (en)
Other versions
AU4147100A (en
Inventor
Seung Won Jin
Chang Gi Lim
Hoon Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Publication of AU4147100A publication Critical patent/AU4147100A/en
Application granted granted Critical
Publication of AU768029B2 publication Critical patent/AU768029B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU41471/00A 1999-04-09 2000-04-10 Method for quantifying transforming growth factor-beta1 and method for detecting cancer by using same Ceased AU768029B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR19990012568 1999-04-09
KR99/12568 1999-04-09
KR19990043935 1999-10-12
KR99/43935 1999-10-12
PCT/KR2000/000329 WO2000062062A1 (fr) 1999-04-09 2000-04-10 Methode de quantification du facteur de croissance transformant beta-1 et methode de detection du cancer a l'aide de ce facteur

Publications (2)

Publication Number Publication Date
AU4147100A AU4147100A (en) 2000-11-14
AU768029B2 true AU768029B2 (en) 2003-11-27

Family

ID=26634921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41471/00A Ceased AU768029B2 (en) 1999-04-09 2000-04-10 Method for quantifying transforming growth factor-beta1 and method for detecting cancer by using same

Country Status (11)

Country Link
EP (1) EP1166112A4 (fr)
JP (1) JP2002541479A (fr)
CN (1) CN1355882A (fr)
AU (1) AU768029B2 (fr)
BR (1) BR0009607A (fr)
CA (1) CA2369892A1 (fr)
ID (1) ID30316A (fr)
MX (1) MXPA01009942A (fr)
NZ (1) NZ514596A (fr)
TR (1) TR200102917T2 (fr)
WO (1) WO2000062062A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2430257A1 (fr) * 2000-11-28 2002-06-06 Amgen, Inc. Molecules associees au facteur de croissance transformant-beta et leurs applications
JP4834835B2 (ja) * 2006-07-27 2011-12-14 国立大学法人浜松医科大学 自閉症の診断薬

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02126157A (ja) * 1988-11-04 1990-05-15 Tosoh Corp ヒトトランスフォーミンググロースファクターβの免疫学的測定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59195162A (ja) * 1983-04-21 1984-11-06 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の検定用試薬
JPS59216058A (ja) * 1983-05-23 1984-12-06 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の定量法
JPS59226864A (ja) * 1983-06-07 1984-12-20 Toyo Jozo Co Ltd トランスホ−ミンググロスファクタ−の酵素免疫測定法
JPS6018764A (ja) * 1983-07-12 1985-01-30 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の免疫測定法
WO1993010215A1 (fr) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Proteaglicane betaglycane purifiee, compositions et procedes
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02126157A (ja) * 1988-11-04 1990-05-15 Tosoh Corp ヒトトランスフォーミンググロースファクターβの免疫学的測定方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF RECEPTOR RESEARCH, VOL. 8 (1-4), 419-436 *

Also Published As

Publication number Publication date
ID30316A (id) 2001-11-22
CA2369892A1 (fr) 2000-10-19
JP2002541479A (ja) 2002-12-03
BR0009607A (pt) 2002-01-08
WO2000062062A1 (fr) 2000-10-19
EP1166112A1 (fr) 2002-01-02
AU4147100A (en) 2000-11-14
EP1166112A4 (fr) 2004-11-10
TR200102917T2 (tr) 2002-03-21
NZ514596A (en) 2003-03-28
MXPA01009942A (es) 2003-07-14
CN1355882A (zh) 2002-06-26

Similar Documents

Publication Publication Date Title
AU750296B2 (en) Antibodies against SEMP1, methods for their production and uses thereof
CN115505043A (zh) 特异性结合糖基化ceacam5的抗体
CN112048019B (zh) 抗人cd47单克隆抗体
AU768029B2 (en) Method for quantifying transforming growth factor-beta1 and method for detecting cancer by using same
CN113480646B (zh) 特异性结合h1.4移码突变蛋白的单克隆抗体制备及其应用
WO2002033094A1 (fr) Anticorps inhibant l'activite vplf
CN110903359B (zh) 一种空肠弯曲菌重组蛋白及其单克隆抗体的制备
CN110951703B (zh) 一种间日疟原虫乳酸脱氢酶重组蛋白及其单克隆抗体的制备
JP3920556B2 (ja) 短縮型ミッドカイン（ｔＭＫ）タンパク質特異的モノクローナル抗体及びその用途
EP1167387A1 (fr) Anticorps anti-SEMP1, procédé pour leur production, et leurs utilisations
JPH05317088A (ja) 腫瘍関連抗原に対するモノクローナル抗体、その製造方法およびその使用
JP3210994B2 (ja) ヒトガストリン放出ペプチド前駆体に対する抗体及びその使用
CN116836940B (zh) 一种氧化低密度脂蛋白的单克隆抗体及分泌其单克隆抗体的杂交瘤细胞株与应用
CN111349170B (zh) 免疫相关gtp酶家族m（irgm）的单克隆抗体及其应用
CN109762058A (zh) 一种重组g-17蛋白及其单克隆抗体的制备
JPH0949836A (ja) 抗体による蛋白質構造の評価方法
CN111349157B (zh) 钙粘附蛋白6的单克隆抗体及其应用
CN111349171B (zh) 过氧化物酶-6的单克隆抗体及其应用
KR100493932B1 (ko) 레지스틴에 대한 단클론 항체, 이의 제조 방법, 및 용도
CN113321730B (zh) Cldn18.2抗体及其应用
CN111349164B (zh) 糖基磷脂酰肌醇锚定糖蛋白（c4.4a）的单克隆抗体及其应用
KR100378746B1 (ko) 체액내 활성 세포증식억제인자-베타1의 정량 방법 및 이를이용한 암 검사 방법
US5786451A (en) 23 Kd human retinal CAR antigen
US7303914B2 (en) Monoclonal antibody against human hepatoma and use thereof
CN110483641B (zh) 干扰素诱导型gtp酶的单克隆抗体及其应用

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)